Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Pravastatin sodium [USAN:USP:JAN]
RN: 81131-70-6
UNII: 3M8608UQ61
InChIKey: VWBQYTRBTXKKOG-IYNICTALSA-M

Note

  • An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES).

Molecular Formula

  • C23-H35-Na-O7

Molecular Weight

  • 446.5125
 

Classification Codes

  • Antihyperlipidemic
  • Drug / Therapeutic Agent
  • Human Data
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Pravastatin sodium [USAN:USP:JAN]

Synonyms

  • 3-beta-Hydroxycompactin sodium salt
  • Aplactin
  • Bristacol
  • CS-514
  • DRG-0319
  • Elisor
  • Epastatin sodium
  • Lipemol
  • Lipidal
  • Lipostat
  • Liprevil
  • Mevalotin
  • NSC 759253
  • Pralidon
  • Prareduct
  • Pravachol
  • Pravacol
  • Pravaselect
  • Pravasin
  • Pravasine
  • Pravastatin Natrium Mayrho Fer
  • Pravastatin sodium
  • Sanaprav
  • Selektine
  • Selipran
  • Sodium (+)-(betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-hexahydro-beta,delta,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2S)-2-methylbutyrate)
  • SQ 31000
  • SQ-31,000
  • UNII-3M8608UQ61
  • Vasen

Systematic Names

  • 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-2-methyl-8-(2-methyl-1-oxobutoxy)-beta,delta,6-trihydroxy-, monosodium salt, (1S-(1-alpha(beta-S*,delta-S*),2-alpha,6-alpha,8-beta(R*),8a-alpha))-
  • 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-

Superlist Name

  • Pravastatin sodium

Mixture Name

  • Pravigard PAC

Registry Numbers

CAS Registry Number

  • 81131-70-6

FDA UNII

  • 3M8608UQ61

Other Registry Numbers

  • 115873-26-2
  • 81131-73-9
  • 85956-24-7
  • 87098-76-8

Related Registry Number

  • 81093-37-0 (Parent)

System Generated Number

  • 0081131706

Structure Descriptors

InChI

InChI=1S/C23H36O7.Na/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28;/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28);/q;+1/p-1/t13-,14-,16+,17+,18+,19-,20-,22-;/m0./s1

InChIKey

VWBQYTRBTXKKOG-IYNICTALSA-M

Smiles

[Na+].CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@@H]12

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
man TDLo oral 16mg/kg/8W-I (16mg/kg) LIVER: "JAUNDICE, CHOLESTATIC"

LIVER: LIVER FUNCTION TESTS IMPAIRED

SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"		 American Journal of Emergency Medicine. Vol. 17, Pg. 1388, 1999.
mouse LD50 intravenous 2011mg/kg (2011mg/kg) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE		 Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 4949, 1987.
mouse LD50 oral 8939mg/kg (8939mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE

BLOOD: CHANGES IN SPLEEN		 Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 4949, 1987.
mouse LD50 subcutaneous 2975mg/kg (2975mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES		 Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 4949, 1987.
rat LD50 intravenous 440mg/kg (440mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)		 Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 4949, 1987.
rat LD50 oral > 12gm/kg (12000mg/kg)   Yakkyoku. Pharmacy. Vol. 40, Pg. 2351, 1989.
rat LD50 subcutaneous 3172mg/kg (3172mg/kg) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

BEHAVIORAL: ATAXIA

SKIN AND APPENDAGES (SKIN): HAIR: OTHER		 Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 4949, 1987.
rat LDLo intraperitoneal 400mg/kg (400mg/kg)   Biochemistry and Molecular Biology International. Vol. 47, Pg. 519, 1999.
women TDLo oral 16800ug/kg (16.8mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Lancet. Vol. 340, Pg. 910, 1992.
women TDLo oral 30mg/kg/21W-I (30mg/kg) SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"

BLOOD: "CHANGES IN SERUM COMPOSITION (E.G., TP, BILIRUBIN, CHOLESTEROL)"

BEHAVIORAL: MUSCLE WEAKNESS		 New England Journal of Medicine. Vol. 327, Pg. 649, 1992.

Physical Properties

Physical Property Value Units Temp (deg C) Source
log P (octanol-water) -0.23 (none)   EXP
Water Solubility 2460 mg/L 25 EST
Vapor Pressure 3.60E-23 mm Hg 25 EST
Atmospheric OH Rate Constant 2.41E-10 cm3/molecule-sec 25 EST

Physical property data is provided to ChemIDplus by SRC, Inc.